US5498729A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Prodrug compositions
Assignee: Individual
•
Filing: 1993-02-22
•
Granted: 1996-03-12
•
Expires: 2013-02-22
Abstract
Abstract Compositions degrading by hydrolysis to release a bioactive compound having carboxylic acid moieties, which are organic acid anhydrides having the following formula: Formula 1: <IMAGE> wherein R' is a residue of a therapeutic bioactive compound, for example, a non-steroidal anti-inflammatory agent; a penicillin or cephalosporin antibiotic; or bioactive compounds for non-therapeutic use, for example, herbicides, insecticides, fungicides, antimicrobials, pesticides, pheromones, and fertilizers; m is an integer of between 1 and 3; and R is a carrier. The resulting mixed anhydrides are characterized by having between one and three drug molecules attached to a single carrier molecule. The prodrugs are highly susceptibility to hydrolytic degradation in a predictable and controlled fashion, have variable solubilities in water and lipids, with increased biomembrane transport, elicit a bio-affecting/pharmacological response, and are less irritating to topical and gastric or intestinal mucosal membranes.
Inventors
- 👤 Abraham J. Domb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:13
CPC Classifications
A; A01; A01N; A01N37/00; A01N37/14; A01N37/18; A01N37/20; A01N39/00; A01N39/02; A01N39/04; A01N49/00; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/542; A61K47/56; A61K47/59; A61K47/60; A61P; A61P29/00; A61P31/00; A61P33/00; A61P33/10; A61P5/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
140 words
A mixed anhydride having the formula ##STR4## wherein R is selected from the group consisting of C 2-24 alkenyl; C 5-6 cycloalkyl; C 2-8 cycloalkenyl; aryl C 1-6 alkyl; C 1-6 alkyl-aryl; CH 3 (CH 2 --CH 2 --O)n, where n is between 1 and 50; CH 3 (CH 2 CHCH 3 O)n, where n is between 1 and 50; lactic and glycolic oligomers of Mn<3,000; caprolactone oligomers of Mn<3,000; amino acids; peptides; saccharides; and heterocyclic compounds, selected from the group consisting of nicotinic acid, and hydroxy, carboxy and halogen substituted nicotinic acids; R' is derived from a compound selected from the group consisting of acetylsalicylic acid; salicylic acid; indomethacin; sulindac; naproxen; fenoprofen; ibuprofen, ketoprofen; diflunisal; tolmetin; flurbiprofen; mefenamic acid; suprofen; and tolfenamic acid; m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 2
Dependent Claim
140 words
A mixed anhydride having the formula ##STR4## wherein R is selected from the group consisting of C 2-24 alkenyl; C 5-6 cycloalkyl; C 2-8 cycloalkenyl; aryl C 1-6 alkyl; C 1-6 alkyl-aryl; CH 3 (CH 2 --CH 2 --O)n, where n is between 1 and 50; CH 3 (CH 2 CHCH 3 O)n, where n is between 1 and 50; lactic and glycolic oligomers of Mn<3,000; caprolactone oligomers of Mn<3,000; amino acids; peptides; saccharides; and heterocyclic compounds, selected from the group consisting of nicotinic acid, and hydroxy, carboxy and halogen substituted nicotinic acids; R' is derived from a compound selected from the group consisting of acetylsalicylic acid; salicylic acid; indomethacin; sulindac; naproxen; fenoprofen; ibuprofen, ketoprofen; diflunisal; tolmetin; flurbiprofen; mefenamic acid; suprofen; and tolfenamic acid; m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 3
Dependent Claim
104 words
A mixed anhydride having the formula ##STR5## wherein R is derived from a compound selected from the group consisting of unsaturated aliphatic acids; aliphatic and aromatic di and tricarboxylic acids, dimer and trimer fatty acids; polyethylene and propylene glycols having carboxylic acid end groups; nicotinic acid; and low molecular weight polymers based on lactic and glycolic acid, R' is derived from a compound selected from the group consisting of acetylsalicylic acid; salicylic acid; indomethacin; sulindac; naproxin; fenoprofen; ibuprofen, ketoprofen; diflunisal; tolmetin; flurbiprofen; mefenamic acid; suprofen; and tolfenamic acid; m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 4
Dependent Claim
104 words
A mixed anhydride having the formula ##STR5## wherein R is derived from a compound selected from the group consisting of unsaturated aliphatic acids; aliphatic and aromatic di and tricarboxylic acids, dimer and trimer fatty acids; polyethylene and propylene glycols having carboxylic acid end groups; nicotinic acid; and low molecular weight polymers based on lactic and glycolic acid, R' is derived from a compound selected from the group consisting of acetylsalicylic acid; salicylic acid; indomethacin; sulindac; naproxin; fenoprofen; ibuprofen, ketoprofen; diflunisal; tolmetin; flurbiprofen; mefenamic acid; suprofen; and tolfenamic acid; m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 5
Dependent Claim
12 words
The mixed anhydride of claim 1 further comprising a pharmaceutically acceptable vehicle.
Claim 6
Dependent Claim
12 words
The mixed anhydride of claim 2 further comprising a pharmaceutically acceptable vehicle.
Claim 7
Dependent Claim
12 words
The mixed anhydride of claim 1, wherein R' is derived from indomethacin.
Claim 8
Dependent Claim
36 words
The anhydride of claim 2, wherein the compound R is derived from is selected from the group consisting of lauric acid, stearic acid, benzenetricarboxylic acid, oleic acid, sebacic acid, adipic acid, isophthalic acid, and nicotinic acid.
Claim 9
Dependent Claim
16 words
The anhydride of claim 2, wherein the compound R is derived from is a fatty acid.
Claim 10
Dependent Claim
152 words
A mixed anhydride having the formula ##STR6## wherein R is derived from a compound selected from the group consisting of lauric acid, stearic acid, benzenetricarboxylic acid, oleic acid, sebacic acid, adipic acid, isophthalic acid, nicotinic acid, or R is selected from the group consisting of C 2-24 alkenyl; C 5-6 cycloalkyl; C 2-8 cycloalkenyl; aryl C 1-6 alkyl; C 1-6 alkyl-aryl; CH 3 (CH 2 --CH 2 --O)n, where n is between 1 and 50; CH 3 (CH 2 CHCH 3 O)n, where n is between 1 and 50; lactic and glycolic oligomers of Mn<3,000; caprolactone oligomers of Mn<3,000; amino acids peptides; saccharides; and heterocyclic compounds, selected from the group consisting of nicotinic acid, and hydroxy, carboxy and halogen substituted nicotinic acids, R' is selected from the group consisting of indomethacin, acetylsalicylic acid, and salicylic acid, m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 11
Dependent Claim
152 words
A mixed anhydride having the formula ##STR6## wherein R is derived from a compound selected from the group consisting of lauric acid, stearic acid, benzenetricarboxylic acid, oleic acid, sebacic acid, adipic acid, isophthalic acid, nicotinic acid, or R is selected from the group consisting of C 2-24 alkenyl; C 5-6 cycloalkyl; C 2-8 cycloalkenyl; aryl C 1-6 alkyl; C 1-6 alkyl-aryl; CH 3 (CH 2 --CH 2 --O)n, where n is between 1 and 50; CH 3 (CH 2 CHCH 3 O)n, where n is between 1 and 50; lactic and glycolic oligomers of Mn<3,000; caprolactone oligomers of Mn<3,000; amino acids peptides; saccharides; and heterocyclic compounds, selected from the group consisting of nicotinic acid, and hydroxy, carboxy and halogen substituted nicotinic acids, R' is selected from the group consisting of indomethacin, acetylsalicylic acid, and salicylic acid, m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 12
Dependent Claim
86 words
A mixed anhydride having the formula ##STR7## wherein R is derived from a compound selected from the group consisting of aliphatic and aromatic di and tricarboxylic acids, benzenetricarboxylic acid, dimer and trimer fatty acids; polyethylene and propylene glycols having carboxylic acid end groups; nicotinic acid; and low molecular weight polymers based on lactic and glycolic acid; R' is selected from the group consisting of indomethacin, acetylsalicylic acid, and salicylic acid, m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 13
Dependent Claim
86 words
A mixed anhydride having the formula ##STR7## wherein R is derived from a compound selected from the group consisting of aliphatic and aromatic di and tricarboxylic acids, benzenetricarboxylic acid, dimer and trimer fatty acids; polyethylene and propylene glycols having carboxylic acid end groups; nicotinic acid; and low molecular weight polymers based on lactic and glycolic acid; R' is selected from the group consisting of indomethacin, acetylsalicylic acid, and salicylic acid, m is an integer of between 1 and 3; and wherein R and R' are different.
Claim 14
Dependent Claim
9 words
The anhydride of claim 8, wherein R' is indomethacin.
Claim 15
Dependent Claim
9 words
The anhydride of claim 9, wherein R' is indomethacin.
References Cited (Backward Citations)
US2236125A
Cited
US2423569A
Cited
US2577699A
Cited
GB1069775A
Cited
GB1175933A
Cited
US3763152A
Cited
BE738726A
Cited
DE2126037A1
Cited
CA1002036A
Cited
US3875224A
Cited
US4851426A
Cited
US4888176A
Cited
US4868201A
Cited
US4863965A
Cited
WO1987002891A1
Cited
US4757128A
Cited
US4789724A
Cited
US4857311A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-12 | 1999-09-11 | 2000-03-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-12 | 2003-09-11 | 2004-03-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-12 | 2007-09-11 | 2008-03-12 | $7700.00 | Window Closed / Lapsed |